2021M&A Transaction Multiples
Home Health Multiples - 2021
Sourced from 22 publicly disclosed Home Health acquisitions in 2021. Public records only (SEC EDGAR + verified press releases).
EV / EBITDA
11.3x
median · p25 5.7x - p75 15.3x · n=14
EV / Revenue
1.3x
median · p25 0.8x - p75 2.0x · n=19
Value your Home Health business
Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.
Home Health multiples by year
Other verticals - 2021 multiples
Aerospace· 15.09x EBITDAAmbulatory Surgery Center· 9.9x EBITDAConsulting· 16.11x EBITDAConsumer Products· 8.5x EBITDADental Practice· 14.6x EBITDADurable Medical Equipment· 5.65x EBITDAEcommerce· 13.05x EBITDAElectronics· 15.62x EBITDAFood Manufacturing· 12.25x EBITDAGaming· 23.39x EBITDAHealthcare IT· 19.48x EBITDAIndustrial Equipment· 18.6x EBITDAIT Services· 11.26x EBITDALaboratory Services· 22.2x EBITDAMedical Devices· 16.5x EBITDAMedical Practice Primary Care· 7x EBITDAMedical Practice Specialty· 6.65x EBITDAMental Health· 14.7x EBITDAMetal Fabrication· 7.29x EBITDAOil Gas Services· 8.25x EBITDAOther· 20.39x EBITDAOther Healthcare· 11.4x EBITDAOther Manufacturing· 11.64x EBITDAOther Personal Services· 11.74x EBITDA
Data sourced from 22 disclosed Home Health M&A transactions in 2021. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →